Preventing Sudden Cardiac Arrest in the Heart Failure Patient

2010 ◽  
pp. 177-195
Author(s):  
Sanjiv M. Narayan
2019 ◽  
Vol 124 (5) ◽  
pp. 751-755 ◽  
Author(s):  
Waqas T. Qureshi ◽  
Abhishek Dutta ◽  
Youssef Masmoudi ◽  
Usama Bin Nasir ◽  
Chaudry Nasir Majeed ◽  
...  

PLoS ONE ◽  
2020 ◽  
Vol 15 (12) ◽  
pp. e0243008
Author(s):  
Marco Antonio Prates Nielebock ◽  
Otacílio C. Moreira ◽  
Samanta Cristina das Chagas Xavier ◽  
Luciana de Freitas Campos Miranda ◽  
Ana Carolina Bastos de Lima ◽  
...  

Background The specific roles of parasite characteristics and immunological factors of the host in Chagas disease progression and prognosis are still under debate. Trypanosoma cruzi genotype may be an important determinant of the clinical chronic Chagas disease form and prognosis. This study aimed to identify the potential association between T. cruzi genotypes and the clinical presentations of chronic Chagas disease. Methodology/principal findings This is a retrospective study using T. cruzi isolated from blood culture samples of 43 patients with chronic Chagas disease. From 43 patients, 42 were born in Brazil, mainly in Southeast and Northeast Brazilian regions, and one patient was born in Bolivia. Their mean age at the time of blood collection was 52.4±13.2 years. The clinical presentation was as follows 51.1% cardiac form, 25.6% indeterminate form, and 23.3% cardiodigestive form. Discrete typing unit (DTU) was determined by multilocus conventional PCR. TcII (n = 40) and TcVI (n = 2) were the DTUs identified. DTU was unidentifiable in one patient. The average follow-up time after blood culture was 5.7±4.4 years. A total of 14 patients (32.5%) died and one patient underwent heart transplantation. The cause of death was sudden cardiac arrest in six patients, heart failure in five patients, not related to Chagas disease in one patient, and ignored in two patients. A total of 8 patients (18.6%) progressed, all of them within the cardiac or cardiodigestive forms. Conclusions/significance TcII was the main T. cruzi DTU identified in chronic Chagas disease Brazilian patients (92.9%) with either cardiac, indeterminate or cardiodigestive forms, born at Southeast and Northeast regions. Other DTU found in much less frequency was TcVI (4.8%). TcII was also associated to patients that evolved with heart failure or sudden cardiac arrest, the two most common and ominous consequences of the cardiac form of Chagas disease.


Heart Rhythm ◽  
2014 ◽  
Vol 11 (4) ◽  
pp. 646-652 ◽  
Author(s):  
Marwan M. Refaat ◽  
Bradley E. Aouizerat ◽  
Clive R. Pullinger ◽  
Mary Malloy ◽  
John Kane ◽  
...  

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
K Kim ◽  
M.G Kang ◽  
J.S Koh ◽  
J.R Park ◽  
S.J Hwang ◽  
...  

Abstract Background Relation of arterial stiffness and cardiovascular disease is well-known. However, there is no data on association between diastolic function and brachial-ankle pulse wave velocity (baPWV) and influence on heart failure outcomes in patients with acute myocardial infarction (AMI). Methods Among patients presenting with AMI, all subjects underwent baPWV and echocardiography were recruited. Diastolic function was categorized by 2016 guideline of ASE/EACVI left ventricular diastolic function. Heart failure outcomes were defined 1) hospitalization for heart failure, 2) cardiac death and 3) sudden cardiac arrest. Results Totally 1,016 subjects were enrolled (FU duration; 3.5±2.0 years, mean age 65±13, predominant male 71.3% and STEMI 40.8%) from 2012 to 2015 in the our University Hospital. Elderly, female, low BMI, higher PWV, HTN, DM and stroke were associated with higher baPWV. Increased arterial stiffness (defined as baPWV ≥1700) had higher prevalence of diastolic dysfunction compared with baPWV <1700 (98.3% vs 86.2%). HF outcomes of 69 events were identified (HF; n=48, cardiac death; n=16, sudden cardiac arrest; n=2, death d/t HF; n=3). In the multivariate analysis, baPWV ≥1700, HTN and low BMI (23 kg/m2) were independent predictors for HF outcomes after adjustment with age, LVEF, DM and stroke (Table 1). Furthermore, KM curve showed that increased arterial stiffness was associated with higher prevalence of diastolic dysfunction and poor outcomes of heart failure (Figure 1). Conclusions In patients with AMI, arterial stiffness was associated with higher prevalence of diastolic dysfunction an independent predictor for heart failure hospitalization and cardiac death. Figure 1. Diastolic dysfunction and HF in AMI Funding Acknowledgement Type of funding source: None


Heart Rhythm ◽  
2020 ◽  
Vol 17 (10) ◽  
pp. 1672-1678
Author(s):  
Orison O. Woolcott ◽  
Kyndaron Reinier ◽  
Audrey Uy-Evanado ◽  
Gregory A. Nichols ◽  
Eric C. Stecker ◽  
...  

Author(s):  
Anne Guimier ◽  
Melanie T. Achleitner ◽  
Anne Moreau de Bellaing ◽  
Matthew Edwards ◽  
Loïc de Pontual ◽  
...  

Abstract Purpose Biallelic hypomorphic variants in PPA2, encoding the mitochondrial inorganic pyrophosphatase 2 protein, have been recently identified in individuals presenting with sudden cardiac death, occasionally triggered by alcohol intake or a viral infection. Here we report 20 new families harboring PPA2 variants. Methods Synthesis of clinical and molecular data concerning 34 individuals harboring five previously reported PPA2 variants and 12 novel variants, 11 of which were functionally characterized. Results Among the 34 individuals, only 6 remain alive. Twenty-three died before the age of 2 years while five died between 14 and 16 years. Within these 28 cases, 15 died of sudden cardiac arrest and 13 of acute heart failure. One case was diagnosed prenatally with cardiomyopathy. Four teenagers drank alcohol before sudden cardiac arrest. Progressive neurological signs were observed in 2/6 surviving individuals. For 11 variants, recombinant PPA2 enzyme activities were significantly decreased and sensitive to temperature, compared to wild-type PPA2 enzyme activity. Conclusion We expand the clinical and mutational spectrum associated with PPA2 dysfunction. Heart failure and sudden cardiac arrest occur at various ages with inter- and intrafamilial phenotypic variability, and presentation can include progressive neurological disease. Alcohol intake can trigger cardiac arrest and should be strictly avoided.


Author(s):  
Sherly Purnamawaty ◽  
Tenri Esa ◽  
Ibrahim Abd Samad

Acute Myocardial Infarction (IMA) is the most severe manifestation of coronary arterial disease, and about 60%-75% ofIMA is NSTEMI. It is known that complications are associated with high mortality rates; therefore, predicting thedevelopment of complications in NSTEMI will help physicians improve risk stratification and determine optimal treatment.Suppression of tumorigenicity-2 (ST2) is a family of interleukin-1 (IL-1) receptors. Ischemia, injury, and myocardial infarctionwill cause cardiomyocytes to release sST2 associated with a worse prognosis. This study aimed to analyze sST2 levels inNSTEMI patients as a prognostic marker. This study used a prospective cohort method performed on NSTEMI patientstreated at Pusat Jantung Terpadu of Dr. Wahidin Sudirohusodo Hospital during March 2019. Forty-two patients wereinvolved as samples. All patients were tested for sST2 levels by immunochromatography and followed up duringhospitalization. Data on the development of heart failure, arrhythmia, cardiogenic shock, sudden cardiac arrest, length ofstay, and outcome were recorded during follow-up. Data were statistically analyzed with Mann-Whitney and Spearman test.The results of the sST2 level in NSTEMI with and without heart failure were 114.09±92.01 ng/mL and 58.94±57.75 ng/mL(p=0.014), respectively. There was no significant difference between sST2 levels in NSTEMI with complications ofarrhythmias, cardiogenic shock, and sudden cardiac arrest compared and patients without those complications (p>0.05).The level of sST2 was significantly higher in NSTEMI patients who passed away (164.05±77.35 ng/mL) than those whosurvived (72.55±73.15 (p=0.027). There was no correlation between sST2 levels and length of stay (p=0.947). It wasconcluded that sST2 levels could be a prognostic marker for NSTEMI, particularly heart failure and outcome.


Author(s):  
Bhavna Hooda ◽  
Saurabh Sud ◽  
Deepak Dwivedi ◽  
Sanjay K. Yadav

AbstractThe anesthetic management of a patient with dilated cardiomyopathy (DCM) for noncardiac surgery is challenging due to associated congestive heart failure, malignant dysrhythmias, sudden cardiac arrest, implanted rhythm devices, and thromboembolism. We report successful conduct of a case of DCM on cardiac resynchronization device with Cauda equina syndrome (CES) under general anesthesia in prone position. The anesthetic concerns specific to the pathophysiology of DCM are also discussed.


Sign in / Sign up

Export Citation Format

Share Document